
This simple finger test may reveal your hidden risk for lung disease
How to know if your joints are super-flexible
Stiff joints can signal trouble, but super-flexible ones may even bring worse news. If you are able to bend your pinkie backward 90 degrees or touch your thumb to your forearm, this may not necessarily be a good thing.Sign of a rare genetic condition, uber-flexible joints may indicate your increased risk of respiratory illnesses and complicated recovery, as per experts.A quick flexibility test at home could help you uncover this hidden risk. This test is done to understand if your joints can go beyond the typical range of motion. Even if your joints are super-flexible, for most it isn't a sign of worry, but for some people, it could mean they may be suffering from a worrisome condition called Ehlers-Danlos syndrome Ehlers-Danlos syndrome affects your connective tissues - your skin, joints and blood vessel walls. People suffering from the condition have overly flexible joints and stretchy, fragile skin, according to mayoclinic.This can become a serious issue if you have a wound that needs stitches, as the skin may not be strong enough to hold them properly. Connective tissue, a complex blend of proteins and other elements, gives your body structure, strength, and flexibility, and when it's compromised, healing becomes much more difficult.A severe form of disorder could cause the walls of your blood vessels, intestines or uterus to rupture. People with the condition may have muscle weakness, including in the muscles that control inhaling and exhaling.Patients may report respiratory issues, including shortness of breath, difficulty with deep inhalation, sleep apnea, coughing, wheezing that mimics asthma and even chest pain that worsens with breathing in. Breathing pattern disorders are also common. For example, people with EDS may unconsciously adopt a 'bracing' pattern, where they hold their inhaled breath for too long," Jeannie Di Bon, a UK-based hypermobility and EDS specialist, told Newsweek.Di Bon, who has EDS, explains that people with the condition often adopt altered breathing patterns as a subconscious way to feel stable. However, this can reduce lung movement, particularly in the lower lungs, creating conditions that increase the risk of infections and complications from illnesses like COVID-19 and pneumonia. Vascular Ehlers-Danlos syndrome is marked by distinctive facial features like a thin nose, small earlobes, and prominent eyes, along with fragile, translucent skin that bruises easily. In fair-skinned individuals, veins may be clearly visible. The condition can weaken major arteries, including the aorta, increasing the risk of life-threatening ruptures. It can also affect the uterus and intestines, potentially leading to dangerous tears.Joint pain and dislocations are common in this disorder as the joints that can move far past the normal range of motion.The disorder, caused by weakened connective tissue, can make your skin unusually stretchy. You might be able to lift a section of skin away from your body more than normal, but it will quickly snap back into place. The skin may also feel exceptionally soft and velvety to the touch.It is also noticed that the skin doesn't heal properly as the stitches used to close a wound often tear out and leave a gaping scar.Doctors often use the Beighton score to evaluate joint flexibility, which, when combined with other symptoms and family history, can help suggest the presence of Ehlers-Danlos Syndrome (EDS). The score is based on five simple flexibility tests: bending the pinkie finger backward 90 degrees, touching the thumb to the forearm, hyperextending the elbows and knees by more than 10 degrees, and bending forward to place palms flat on the floor without bending the knees. Each maneuver scores one point per side, except the last, which is a single score.A total score above five in adults (or six in children) indicates hypermobility and could be a reason to consult a medical professional about the possibility of EDS.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
2 hours ago
- Time of India
4 gut-friendly foods every woman should add to her diet
Dr. Saurabh Sethi recommends incorporating specific foods into your diet to enhance gut health, particularly beneficial for women's hormone balance, immunity, and mood. Leafy greens, blueberries, fermented foods like homemade yogurt and kefir, and pumpkin seeds are highlighted for their magnesium, fiber, antioxidants, probiotics, zinc, and digestive benefits. These choices support a healthy gut microbiome and overall well-being. Gut health is crucial for overall well-being. When it comes to women, it is even more crucial, as gut health is intricately tied to hormones, immunity, and mood. Keeping the gut happy and healthy is the first step towards a healthy lifestyle. But how does one keep the gut in top shape? Good diet. Dr. Saurabh Sethi, a California-based gastroenterologist, has shared a list of foods that one can add to the diet to boost gut health. Leafy greens Mums are never wrong. They have been telling us to eat greens since childhood. Well, its time to finally listen to them. Greens, especially leafy greens, are good for health. Dr. Sethi noted that magnesium and fiber are two essential nutrients for gut health. Magnesium helps to relax the intestinal muscles and aids in regular bowel movement. It also reduces cramping in women. Fiber, on the other hand, is fuel for beneficial gut bacteria. It also bulks up the stool and prevents constipation. You can add leafy greens like spinach, kale, and Swiss chard to your daily routine. They can be sautéed with other veggies or added to smoothies. Blueberries Who knew boosting gut health could be a delectable habit! Blueberries make your gut happy and healthy. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like American Investor Warren Buffett Recommends: 5 Books For Turning Your Life Around Blinkist: Warren Buffett's Reading List Undo These berries are rich in antioxidants and polyphenols, which prevent inflammation and nourish gut bacteria. The polyphenols also support brain health, by improving mood and cognitive function. You can have blueberries as a snack o, or toss them into yogurt for a creamy treat. Fermented foods Fermented foods such as yogurt, and, kefir are loaded with probiotics, which foster the healthy gut microbiome. However, it is important to go for home-made fermented foods. Because the store-bought foods are often loaded with preservatives, which kill their protective effects. Dr. Sethi also added that fermented foods such as yogurt and kefir are also good for women, as they support the vaginal microbiome and reduce the risk of infections like yeast overgrowth. Also, ensure to choose unsweetened, plain yogurt or kefir. Excessive sugar can disrupt the beneficial gut microbiome. You can add yogurts for smoothies or have it as a side during meals. 5 Seeds that can help in quick weight loss Pumpkin seeds Pumpkin seeds are a nutritious addition to your diet. They are rich in zinc and fiber, which support immune and digestive health. Zinc helps to maintain a healthy gut lining, which prevents issues like leaky gut syndrome. The fiber in pumpkin seeds, on the other hand, promotes digestion. You can add them to your breakfast, or sprinkle them on salads, blend them into smoothies, or even enjoy them roasted as a snack.


Time of India
2 hours ago
- Time of India
'Blood clots surge like never before…': McCullough drops COVID vaccine bombshell at Senate hearing - The Economic Times Video
The U.S. Senate's Permanent Subcommittee on Investigations held a crucial hearing titled "The Corruption of Science and Federal Health Agencies: How Health Officials Downplayed and Hid Myocarditis and Other Adverse Events Associated with the COVID-19 Vaccines." Top medical experts and legal voices testified, including Dr. Peter McCullough, Dr. Jordan Vaughn, Dr. James Thorp, Dr. Joel Wallskog, Attorney Aaron Siri and Hawaii Governor Josh Green. Dr. McCullough presented findings from a large autopsy series, stating that in 73.9% of examined post-vaccine deaths, mRNA COVID vaccines were considered the likely cause, a claim that has sparked intense debate in the medical community.


Economic Times
4 hours ago
- Economic Times
Potential US tariff a significant 'unknown' for business, says Dr Reddy's Lab CEO
Dr. Reddy's Laboratories is closely monitoring a potential US tariff on the pharma sector, viewing it as both a risk and opportunity. The company plans a significant expansion with the generic version of semaglutide across 87 countries by 2026, alongside developing 26 GLP-1 products over the next decade. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads A potential US tariff on the pharma sector is a significant 'unknown' and will be one of the key developments for Dr Reddy's Laboratories to watch over the next few quarters, its chief executive officer, Erez Israeli , told ET.'Don't know whether to call it a risk, but it is an unknown that could develop into a risk, and that is the tariff. We will know better as time will come about what it means and what we can do,' Israeli said over an earning call on Wednesday. 'It's not necessarily bad, it can also create an opportunity. It very much depends on what will be our relative situation to Chinese players or others.'The Hyderabad-based drug maker, which announced its first-quarter earnings, is betting big on generic version of Novo Nordisk 's weight loss molecule semaglutide – that it plans to launch in 87 countries in 2026 - as a future growth driver.'Our levers for the future consist of double-digit growth of the main business and then on top of it the success of semaglutide, which is very important to us, business development and our ability to optimise our resources,' Israeli said in response to ET's query.'We are planning to launch semaglutide in 87 countries as the patent in the relevant country will allow us… We have some countries where there is no active patent as we speak, and in those we can launch. In the other countries, we need to wait for the patent expiration - for example Brazil or India - in which the patent goes on till March 2026. We are absolutely ready to launch on day 1 (post patent expiry) in each one of these markets,' he company which is among the frontrunners for GLP-1 drugs is looking at launching 26 other products in the space over the next decade.'We have 26 products (all peptides) in the GLP1 pipeline and will be launched over the next decade, according to the patent situation,' said Wednesday, the company reported consolidated revenue for the first quarter at Rs 8,545 crore, an 11% increase from a year ago, mainly on account of contributions from its acquired consumer healthcare portfolio in nicotine replacement therapy (NRT) and sustained performance in branded markets. Net profit for the quarter stood at Rs 1,418 crore, up 2% said an ongoing litigation over semaglutide with innovator company Novo Nordisk in India is not likely to hamper its planned product company's global generics revenue in Q1FY26 stood at Rs 7,562 crore, a growth of 10% revenue from North America–one of its key markets–declined 11% y-o-y to Rs 3,412 crore due to increased price erosion in select products, including lenalidomide. Its Europe revenue stood at Rs 1,274 crore, up 142% on account of NRT portfolio company's India and emerging markets business grew 11% and 17% company's EBITDA margin for the first quarter stood at 26.7%.